Cargando…

Autoantibodies in Neuropsychiatric Disorders

Little is known about the etiology of neuropsychiatric disorders. The identification of autoantibodies targeting the N-methyl-d-aspartate receptor (NMDA-R), which causes neurological and psychiatric symptoms, has reinvigorated the hypothesis that other patient subgroups may also suffer from an under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffmann, Carolin, Zong, Shenghua, Mané-Damas, Marina, Molenaar, Peter, Losen, Mario, Martinez-Martinez, Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698850/ https://www.ncbi.nlm.nih.gov/pubmed/31557990 http://dx.doi.org/10.3390/antib5020009

Ejemplares similares

Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?
por: Zong, Shenghua, et al.
Publicado: (2017)

Addendum: Hoffmann, C.; et al. Autoantibodies in Neuropsychiatric Disorders. Antibodies 2016, 5, 9
por: Hoffmann, Carolin, et al.
Publicado: (2018)

Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1
por: Zong, Shenghua, et al.
Publicado: (2023)

Unidentified Neuronal Surface IgG Autoantibodies in a Case of Hashimoto's Encephalopathy
por: Mané-Damas, Marina, et al.
Publicado: (2020)

Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety
por: Zong, Shenghua, et al.
Publicado: (2020)

Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders
por: Martinez-Martinez, Pilar, et al.
Publicado: (2013)

Autoimmune Encephalitis With mGluR1 Antibodies Presenting With Epilepsy, but Without Cerebellar Signs: A Case Report
por: Vinke, Anita M., et al.
Publicado: (2022)

Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder
por: Hoffmann, Carolin, et al.
Publicado: (2018)

Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
por: Takata, Kazushiro, et al.
Publicado: (2019)

Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
por: Fichtner, Miriam L., et al.
Publicado: (2022)

IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies
por: Koneczny, Inga, et al.
Publicado: (2022)

Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers
por: Sato, Shuzo, et al.
Publicado: (2020)

Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus
por: Cocco, Cristina, et al.
Publicado: (2023)

Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors — Recommendations for methods and experimental designs
por: Losen, Mario, et al.
Publicado: (2015)

Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders
por: del Valle, Eva, et al.
Publicado: (2023)

Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys
por: Losen, Mario, et al.
Publicado: (2017)

The genetics of neuropsychiatric disorders
por: Bray, Nicholas J., et al.
Publicado: (2018)

Autoantibodies and neuropsychiatric manifestations in childhood-onset systemic lupus erythematosus
por: Postal, Mariana, et al.
Publicado: (2014)

The Histaminergic System in Neuropsychiatric Disorders
por: Cheng, Li, et al.
Publicado: (2021)

Gut Bacteria and Neuropsychiatric Disorders
por: Dicks, Leon M. T., et al.
Publicado: (2021)

Influence of gut microbiota on neuropsychiatric disorders
por: Cenit, María Carmen, et al.
Publicado: (2017)

Gut microbiome in neuropsychiatric disorders
por: MEJÍA-GRANADOS, Diana Marcela, et al.
Publicado: (2022)

Autoantibody Biomarkers for Basal Ganglia Encephalitis in Sydenham Chorea and Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infections
por: Chain, Jennifer L., et al.
Publicado: (2020)

Pluripotent stem cells in neuropsychiatric disorders
por: Soliman, M A, et al.
Publicado: (2017)

MMPs in learning and memory and neuropsychiatric disorders
por: Beroun, Anna, et al.
Publicado: (2019)

Neuropsychiatric disturbances in atypical parkinsonian disorders
por: Belvisi, Daniele, et al.
Publicado: (2018)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
por: Shen, Yao, et al.
Publicado: (2022)

Impact of COVID-19 on Neuropsychiatric Disorders
por: Zia, Niloufar, et al.
Publicado: (2022)

The Role of Tryptophan Metabolites in Neuropsychiatric Disorders
por: Davidson, Majid, et al.
Publicado: (2022)

BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders
por: Bazzari, Amjad H., et al.
Publicado: (2022)

Copy Number Variations in Neuropsychiatric Disorders
por: Büki, Gergely, et al.
Publicado: (2023)

Noteworthy perspectives on microglia in neuropsychiatric disorders
por: Zhu, Hongrui, et al.
Publicado: (2023)

Roles and mechanisms of ankyrin-G in neuropsychiatric disorders
por: Yoon, Sehyoun, et al.
Publicado: (2022)

Epigenetics of Subcellular Structure Functioning in the Origin of Risk or Resilience to Comorbidity of Neuropsychiatric and Cardiometabolic Disorders
por: Zapata-Martín del Campo, Carlos Manuel, et al.
Publicado: (2018)

NMDA Receptor Activity in Neuropsychiatric Disorders
por: Lakhan, Shaheen E., et al.
Publicado: (2013)

Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer’s Disease and Control Mice
por: den Hoedt, Sandra, et al.
Publicado: (2021)

Redox Modulations, Antioxidants, and Neuropsychiatric Disorders
por: Fraunberger, Erik A., et al.
Publicado: (2016)

Ethopharmacology: Primate Models of Neuropsychiatric Disorders
por: Krystal, John H.
Publicado: (1984)

Crosstalk between metabolic and neuropsychiatric disorders
por: Kaidanovich-Beilin, Oksana, et al.
Publicado: (2012)

Modulating Neuroinflammation to Treat Neuropsychiatric Disorders
por: Radtke, Franziska A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kcitikbqqeuop5mu39c2tgsu7a